Cargando…
Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: study protocol for an international, multicenter, diagnostic trial
BACKGROUND: At the time of surgery, approximately 10–20% of the patients with pancreatic cancer are considered unresectable because of unexpected liver metastasis, peritoneal carcinomatosis or locally advanced disease. This leads to futile surgical treatment with all the associated morbidity, mortal...
Autores principales: | Litjens, G., Rivière, D. M., van Geenen, E. J. M., Radema, S. A., Brosens, L. A. A., Prokop, M., van Laarhoven, C. J. H. M., Hermans, J. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418197/ https://www.ncbi.nlm.nih.gov/pubmed/32778061 http://dx.doi.org/10.1186/s12885-020-07226-0 |
Ejemplares similares
-
Routine contrast-enhanced CT is insufficient for TNM-staging of duodenal adenocarcinoma
por: Litjens, G., et al.
Publicado: (2022) -
Computed Tomography-Based Radiomics Using Tumor and Vessel Features to Assess Resectability in Cancer of the Pancreatic Head
por: Litjens, Geke, et al.
Publicado: (2023) -
Effects of disulfiram on apoptosis in PANC-1 human pancreatic cancer cell line
por: Dastjerdi, M. Nikbakht, et al.
Publicado: (2014) -
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus
por: LIU, LING, et al.
Publicado: (2013) -
A Diagnostic Challenge:
Pancreatic Cancer or Autoimmune Pancreatitis?
por: CAZACU, I.M., et al.
Publicado: (2018)